1 - Free
1. Atkins CE, Brown WA, Coats JR, Crawford MA, DeFrancesco TC, Edwards J, Fox PR, Keene BW, Lehmkuhl L, Luethy M, Meurs K, Petrie JP, Pipers F, Rosenthal S, Sidley JA, Straus J (2002)
Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation
J Am Vet Med Assoc. 2002; 22: 654-8
2. Atkins CE, Keene BW, Brown WA, Coats JR, Crawford MA, Defrancesco TC, Edwards NJ, Fox PR, Lehmkuhl LB, Luethy MW, Meurs KM, Petrie JP, Pipers FS, Rosenthal SL, Sidley JA, Straus JH (2007)
Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency
J Am Vet Med Assoc. 2007; 231: 1061-9
3. Atkins CE, Rausch WP, Gardner SY, Defrancesco TC, Keene BW, Levine JF (2007)
The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog
J Vet Pharmacol Ther. 2007; 30: 394-400
4. Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Häggström J, Hamlin R, Keene B, Luis-Fuentes V, Stepien R (2009)
Guidelines for the diagnosis and treatment of canine chronic valvular heart disease
J Vet Intern Med. 2009; 23:1142-50
5. Atkins CE (2007)
ACE-inhibitors in asymptomatic mitral regurgitation
In: Proceedings of the NAVC Congress. Orlando, 2007, 144
6. Atkinson KJ, Fine DM, Thombs LA, Gorelick JJ, Durham HE (2009)
Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs
J Vet Intern Med. 2009; 23: 1190-6
7. Bach JF, Rozanski EA, Macgregor J, Betkowski JM, Rush JE (2006)
Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs
J Vet Intern Med. 2006; 20: 1132-5
8. Bernay F, Bland JM, Häggström J, Baduel L, Combes B, Lopez A, Kaltsatos V (2010)
Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease
J Vet Intern Med. 2010; 24: 331-41
9. Bomassi E (2007)
Principe actif le pimobendane
Nouv. prat. vét. canine féline. 2007; 31: 60-63
10. Bomassi E (2006)
Thérapeutique. L’utilisation raisonnée des IECA lors d’insuffisance cardiaque chez le chien et le chat
Nouv. Prat. Vét. canine féline. 2006, 33-3
11. Bonagura JD, Schober KE (2009)
Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease ?
J Small Anim Pract. 2009;50 Suppl 1:12-24
12. Booth MA, Atkins CE, Fujii Y, Adams AK, Defrancesco TC, Keene BW (2007)
The effect of pimobendan on the renin-angiotensin-aldosterone system and arrhythmogenesis in the dog
J Vet Intern Med. 2007; 21: 610-1
13. Borgarelli M, Tarducci A, Zanatta R, Haggström J (2007)
Decreased systolic function and inadequate hypertrophy in large and small breed dogs with chronic mitral valve insufficiency
J Vet Intern Med. 2007; 21: 61-67
14. Borgarelli M, Savarino P, Crosara S, Santilli RA, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, Tarducci A (2008)
Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease
J Vet Intern Med. 2008; 22: 120-8
15. Boswood A (2008)
Comment je traite… La Maladie Valvulaire Dégénérative chez le chien
Veterinary Focus. 2008; 18: 25-31
16. Boswood A (2009)
New standard of care in canine CHF treatment : what do the clinical trials mean for the veterinary practitioner ?
In: Proceedings of the NAVC Conference. Orlando, 2009, 179-181
17. Buchanan JW (1977)
Chronic valvular disease (endocardiosis) in dogs
Advt Vet Sci. 1977; 21: 57-10
18. BULMER BJ, SISSON DD (2005)
Therapy of heart failure
In : Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 948-72
19. Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, Salvucci F, Maestri R, Sisti M, Cobelli F, Tavazzi L (1997)
Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function
Am Heart J. 1997; 134: 1089-98
20. Chandrashekhar Y, Prahash AJ, Sen S, Gupta S, Roy S, Anand IS (2003)
The role of arginine vasopressin and its receptors in the normal and failing rat heart
J Mol Cell Cardiol. 2003; 35: 495-504
21. CHETBOUL V, POUCHELON JL, BUREAU-AMAGLIO S, TESSIER D ( 1999)
Echocardiographie et examen Doppler lors de cardiopathies
In : Echocardiographie et écho-doppler du chien et du chat. 1999, Masson; 69-136
22. Chetboul V (2002)
Traitement de l’insuffisance cardiaque. Choix et suivi du traitement de l’insuffisance cardiaque
Point. Vét. 2002; 33, numéro spécial: cardiologie du chien et du chat: 22-27
23. Chetboul V (2006)
Traitement de l’insuffisance mitrale chez le chien
Prat. Vét. Anim. Cie. 2006; 31: 7-10
24. Chetboul V, Lefebvre HP, Carlos Sampedrano C, Gouni V, Saponaro V, Serres F, Concordet D, Nicolle AP, Pouchelon JL (2007)
Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease : a prospective, controlled, blinded and randomized study
J Vet Intern Med. 2007; 21: 742-753
25. Chiong JR, Cheung RJ (2010)
Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.
Clin Cardiol. 2010; 33: 345-52
26. Chua TP, Ponikowski P, Webb-Peploe K, Harrington D, Anker SD, Piepoli M, Coats AJ (1997)
Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex
Eur Heart J. 1997; 18: 480-486
27. Corcoran BM, Black A, Anderson H, Dukes McEvan J, French A (2002)
Investigation of mitral valve morphology in dogs with mitral valve endocardiosis using scanning electron microscopy
In : Proceedings of the 12th European College of Veterinary Internal Medecine/European Society of Veterinary Internal Medecine Congress. Munich, 2002: 178; 19-21
28. Corcoran BM, Black A, Anderson H, McEwan JD, French A, Smith P, Devine C (2004)
Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration
Am J Vet Res. 2004; 65: 198-206
29. Crosara S, Borgarelli M, La Rosa G, Savarino P, Bellino C, Zanatta R, Haggstrom J, Tarducci A (2007)
Natural history and risk predictors of chronic degenerative mitral valve disease in asymptomatic dogs
J Vet Intern Med 2007; 21: 1420-1445
30. DARKE PGG (1987)
Valvular incompetence in Cavalier King Charles spaniels
Vet Rec. 1987; 120: 365-366
31. DAVIDOFF F, HAYNES RB, SACKETT DL, SMITH R (1995)
Evidence-based medicine
Br Med J. 1995; 310: 1085-6
32. Drexler H, Hornig B (1996)
Importance of endothelial function in chronic heart failure
J Cardiovasc Pharmacol. 1996; 27: S9-S12
33. DE MORAIS HA, SCHWARTZ DS (2005)
How does the body react to heart failure ?
In : Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 921-930
34. Disatian S, Ehrhart EJ 3rd, Zimmerman S, Orton EC (2008)
Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation
Heart Valve Dis. 2008; 17: 402-1
35. Drexler H, Hornig B (1996)
Importance of endothelial function in chronic heart failure
J Cardiovasc Pharmacol. 1996; 27: S9-12
36. Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, hanson PD (1998)
Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group
J Am Vet Med Assoc. 1998; 213: 1573-7
37. Falk T, Jönsson L (2000)
Ischaemic heart disease in the dog : a review of 65 cases
J Small Anim Pract. 2000; 41: 97-103
38. Falk T, Jönsson L, Olsen LH, Pedersen HD (2006)
Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease
Cardiovasc Pathol. 2006; 15: 185-93
39. Falk T, Jönsson L, Olsen LH, TARNOW I, PEDERSEN HD (2007)
Correlation of cardiac pathology and clinical findings in dogs with naturally occuring congestive heart failure
In: Proceedings of the 17th annual ECVIM congress. Budapest, Hungary, 2007; Abstract 23
40. Freeman LM, Rusch JE (2008)
Maladies cardiovasculaires : influence de l’alimentation
In: Encyclopédie de la nutrition clinique, Royal Canin. 2008; 335-347
41. Fujii Y, Orito K, Muto M, Wakao Y (2007)
Modulation of the tissue renin-angiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve
Am J Vet Res. 2007; 68: 1045-50
42. Gerling IC, Sun Y, Ahokas RA, Wodi LA, Bhattacharya SK, Warrington KJ, Postlethwaite AE, Weber KT (2003)
Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
Am J Physiol Heart Circ Physiol. 2003;285: H813-21
43. GOGNY M, SOUILHEM W (2003)
Principe actif la spironolactone
Nouv Prat Vét canine féline. 2003; 11: 53-54
44. Gordon SG, Miller MW, Saunders AB (2006)
Pimobendan in heart failure therapy – a silver bullet ?
J Am Anim Hosp Assoc. 2006;42: 90-3
45. Häggström J, HANNSON K, KVART C, SWENSON L (1992)
Chronic valvular disease in the Cavalier King Charles spaniel in Sweden
Vet Res. 1992; 131: 549-553
46. Häggström J, hamlin rl, hansson k, kvart c (1996)
Heart rate variability in relation to severity of mitral regurgitation in Cavalier King Charles spaniels
J Small Anim Pract. 1996; 37: 69-75
47. Häggström J, Hansson K, Karlberg BE, Kvart C, Madej A, Olsson K (1996)
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation
Am J Vet Res. 1996; 57: 1645-52
48. Häggström J, Hansson K, Kvart C, Karlberg BE, Vuolteenaho O, Olsson k (1997)
Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs
Am J Vet Res. 1997; 58: 77-82
49. Häggström J, Duelund Pedersen H, Kvart C (2004)
New insights into degenerative mitral valve disease in dogs
Vet Clin North Am Small Anim Pract. 2004; 34: 1209-26
50. Häggström J., Kvart C., Pedersen HD (2005)
Acquired Valvular Heart Disease
In : Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 1022-35
51. Häggström J., Kvart C., Pedersen HD (2005)
Heart failure
In : Ettinger SJ, Feldman EC, editors, Textbook of veterinary internal medicine, diseases of the dog and cat. St-Louis: Elsevier Saunders; 2005, 405-406
52. Häggström J, Boswood A, O’Grady M et al (2008)
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occuring myxomatous mitral valve disease : the QUEST study
J Vet Intern Med. 2008; 22:1124-35
53. Häggström J, Höglund K, Borgarelli M (2009)
An update on treatment and pronostic indicators in canine myxomatous mitral valve disease
J of Small Anim Pract. 2009; 50: S25-33
54. Hamlin RL, Nakayama T (1998)
Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles
J Vet Intern Med. 1998; 12: 93-5
55. Han RI, Black A, Culshaw GJ, French AT, Else RW, Corcoran BM (2008)
Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease
Am J Vet Res. 2008; 69: 763-9
56. Hansson K, Häggström J, Kvart C, Lord P (2009)
Reader performance in radiographic diagnosis of signs of mitral regurgitation in cavalier King Charles spaniels
J of Small Anim Pract. 2009; 50: S44-53
57. Harris P (1987)
Congestive cardiac failure: central role of the arterial blood pressure
Br Heart J. 1987; 58:190-203
58. Hugonnard M, Bublot I, Cadoré JL, Goy-thollot I (2002)
Conduite thérapeutique chez le chien âgé qui tousse
Point Vét. 2002; 33: 44-8
59. Kanno K, Kuse H, Kawasaki M, Hara A, Kano R, Sasaki Y (2007)
Effects of pimobendan for mitral valve regurgitation in dogs
J Vet Med Sci. 2007; 69: 373-7
60. Keene BW, Bonagura JD (2009)
Management of heart failure in dogs
In: Bonagure JD, Twedt DC, editors, Kirk’s current veterinary therapy, small animal practice. St-Louis: Elsevier Saunders; 2009, 769-86
61. Keene BW, haggstrom J, Boswood A (2009)
Best care practices for canine heart failure treatment
In: Proceedings of the NAVC Conference. Orlando, 2009, 201-2
62. Kellum HB, Stepien RL (2007)
Sildenafil citrate therapy in 22 dogs with pulmonary hypertension
J Vet Intern Med. 2007; 21: 1258-64
63. KEROACK S, TRONCY E (2002)
Traitement d’urgence de l’œdème pulmonaire aigu
Point Vét. 2002; 33, numéro spécial : actualités thérapeutiques en cardiologie du chien et du chat: 112-5
64. Kim S, Iwao H (2000)
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
Pharmacol Rev. 2000; 52: 11-34
65. KITTLESON MG, JOHNSON LE, OLIVER NB (1985)
Acute hemodynamics effects of hydralazine in dogs with chronic mitral regurgitation
J Am Vet Med Assoc. 1985; 187: 258-61
66. Kittleson MD (1998)
Myxomatous atrioventricular degeneration
In: Kittleson MD, Kienle RD, editors, Mosby, Small animal cardiovascular medecine; 297-318
67. Kjaer A, Hesse B (2001)
Heart failure and neuroendocrine activation : diagnostic, pronostic and therapeutic perspectives
Clin Physiol. 2001; 21: 661-72
68. KOGURE K (1980)
Pathology of chronic mitral valvular disease in the dog
Jpn J Vet Sci. 1980; 42: 323-335
69. Kvart C, Haggstrom J, Pedersen HD, Hansson K, eriksson A, Jarvinen AK, Tidholm A, Bsenko K, Ahlgren E, Ilves M, Ablad B, Falk T, Bjerkas E, Gundler S, lord P, Wegeland G, Adolfsson E, Corfitzen J (2002)
Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation
J Vet intern med. 2002;16: 80-8
70. KVEIBORG B, MAJOR-PETERSEN A, CHRISTIANSEN B, TORP-PEDERSEN C (2007)
Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial
Vasc Health Risk Manag. 2007; 3: 31-7
71. LEFEBVRE HB (2004)
Les différentes classes thérapeutiques
In: Chetboul V, Lefebvre HP, Tessier-Vetzel D, Pouchelon JL, editors. Thérapeutique cardiovasculaire du chien et du chat. Paris: Masson-AFVAC; 2004, 17-40
72. Lefèvre C, Goby L (2005)
Le tout premier symposium sur l’endocardiose mitrale chez le chien ouvre de nouveaux horizons dans le domaine de la recherche, des soins et du traitement
Prat Vét Anim Cie. 2005; 24: S11-5
73. Lombard CW, spencer cp (1985)
Correlation of radiographic, echocardiographic and electrocardiographic signs of left heart enlargement in dogs with mitral regurgitation
Vet Radiol. 1985; 26: 89-97
74. Lombard CW, Jöns O, Bussadori CM (2006)
Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs
J Am Anim Hosp Assoc. 2006; 42: 249-61
75. Mallery KF, Freeman LM, Harpster NK, Rush JE (1999)
Factors contributing to the decision for euthanasia of dogs with congestive heart failure
J Am Vet Med Assoc. 1999; 214: 1201-4
76. Marcondes Santos M, Strunz CM, Larsson MH (2006)
Correlation between activation of the sympathetic nervous system estimated by plasma concentrations of norepinephrine and Doppler echocardiographic variables in dogs with acquired heart disease
Am J Vet Res. 2006; 67: 1163-8
77. Marcondes Santos M, Tarasoutchi F, Mansur AP, Strunz CMC (2007)
Effects of carvedilol treatment in dogs with chronic mitral valvular disease
J Vet Intern Med. 2007; 21: 996-1001
78. Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH (2008)
Sodium nitroprusside for advanced low-output heart failure
J Am Coll Cardiol. 2008; 52: 200-7
79. Nicolle AP, Chetboul V, Allerheiligen T, Pouchelon JL, Gouni V, Tessier-Vetzel D, Sampedrano CC, Lefebvre HP (2007)
Azotemia and glomerular filtration rate in dogs with chronic valvular disease
J Vet Intern Med. 2007; 21: 943-9
80. O'Connor CM, Carson PE, Miller AB, Pressler ML, Belkin RN, Neuberg GW, Frid DJ, Cropp AB, Anderson S, Wertheimer JH, DeMets DL (1998)
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation
Am J Cardiol. 1998; 82: 881-7
81. Olsen L, Fredholm M, Pedersen H (1999)
Epidemiology and inheritance of mitral valve prolapse in Dachshunds
J Vet Intern Med. 1999; 13: 448-56
82. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA (2006)
Controversies in ventricular remodelling
Lancet. 2006; 367: 356-67
83. O’Sullivan ML, O’Grady MR, Walker C (2007)
Frequency of ventricular ectopy in dogs with chronic mitral valve disease and congestive heart failure treated with pimobendan or benazepril
J Vet Intern Med. 2007; 21: 587
84. Ouellet M, Difruscia R, belanger MC (2007)
Evaluation of pimobendan in the treatement of early mitral valve disease
J Vet Intern Med. 2007; 21: 610
85. Oyama MA, Chittur SV (2006)
Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease
Am J Vet Res. 2006; 67:1307-18
86. Oyama M, Rush JE, O’Sullivan ML, Williams RM, Rozanski EA, Petrie JP, Sleeper MM, Brown DC (2008)
Perceptions and priorities of owners of dogs with heart disease regarding quality versus quantity of life for their pets
J Am Vet Med Assoc. 2008; 233: 104-8
87. Oyama MA (2009)
Treating canine heart failure : from start to finish
In: Proceedings of the NAVC Conference. Orlando, 2009, 210-1
88. Oyama MA (2009)
How et when to use pimobendan
In: Proceedings of the NAVC Conference. Orlando, 2009, 212-3
89. Oyama MA (2009)
Neurohormonal activation in canine degenerative mitral valve disease : implications on pathophysiology and treatment
J of Small Anim Pract. 2009; 50: S3-11
90. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL (1996)
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group
N Engl J Med. 1996; 335: 1107-14
91. Parker JD, Thiessen JJ (2004)
Increased endothelin-1 production in patients with chronic heart failure
Am J Physiol Heart Circ Physiol. 2004, 286 :H1141-H1145
92. Pedersen HD (1999)
Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: epidemiology and prognostic significance for regurgitation
Vet Rec. 1999; 144: 315
93. PEDERSEN HD, HÄGGSTRÖM J, FALK T, MOW T, OLSEN LH, IVERSEN L ET AL (1999)
Auscultation in mild mitral regurgitation in dogs: observer variation, effects of physical maneuvers, and agreement with color doppler echocardiography and phonography
J Vet Intern Med., 1999; 13: 56-64
94. PEDERSEN HD (2000)
Mitral valve prolapse in the dog: pathogenesis, pathophysiology, diagnosis and comparative aspects of early myxomatous mitral valve disease
Thèse Med Vet., Copenhague, 2000; 100p
95. Peery GJ, Wei CC, Hankes GH, Dillon SR, Ryndres P, Mukherjee R, et al (2002)
Angiotensin II receptor blockade does not improve left ventricular function and remodelling in subacute mitral regurgitation in the dog
J Am Coll Cardiol. 2002; 39: 1374-9
96. PLUMB DC (2005)
Veterinary drug handbook (fifth edition)
Stockholm: PharmaVet, Inc; 2005
97. Pouchelon JL, Jamet N, Gouni V, Tissier R, Serres F, Carlos Sampedrano C, Castaignet M, Lefebvre HP, Chetboul V (2008)
Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease : a restrospective study of 141 cases
J Vet Intern Med. 2008; 22: 905-14
98. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJ (1997)
Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure
Circulation. 1997; 96:2586-94
99. Reynolds C, Oyama M (2008)
Intérêt des biomarqueurs en cardiologie
Veterinary Focus. 2008; 18: 2-6
100. Riegger AJ (1990)
Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure
Eur Heart J. 1990; 11: S79-83
101. Roche BM, Schwartz D, Lehnhard RA, McKeever KH, Nakayama T, Kirby TE, Robitaille PM, Hamlin RL (2002)
Changes in concentrations of neuroendocrine hormones and catecholamines in dogs with myocardial failure induced by rapid ventricular pacing.
Am J Vet Res. 2002; 63: 1413-17
102. Rosenthal SL, Ferguson MJ, Lefbom MK, Tyrrel WD (2006)
Association of pimobendan with ventricular arrhythmias in dogs with congestive heart failure
J Vet Intern Med. 2006; 20: 731
103. Rousselot JF (2000)
Effet d’un IECA sur la pression artérielle chez le chien insuffisant cardiaque
Prat Med Chir Anim Cie. 2000; 35: 29-34
104. Rush JE, Freeman LM, Brown DJ, Brewer BP, Ross JN, Markwell PJ (2000)
Clinical, Echocardiographic, and Neurohormonal Effects of a Sodium-Restricted Diet in Dogs with Heart Failure
J Vet Intern Med. 2000; 14: 513–20
105. Rush JE, Lee ND, Freeman LM, Brewer B (2006)
C-reactive protein concentration in dogs with chronic valvular disease
J Vet Intern Med. 2006; 20: 635-9
106. Serfass P, Chetboul V, Sampedrano CC, Nicolle A, Benalloul T, Laforge H, Gau C, Hébert C, Pouchelon JL, Tissier R (2006)
Retrospective study of 942 small-sized dogs: Prevalence of left apical systolic heart murmur and left-sided heart failure, critical effects of breed and sex
J Vet Cardiol. 2006; 8: 11-8
107. Serres FJ, Chetboul v, Tissier R, Sampedrano CC, Gouni V, Nicolle AP, Pouchelon JL (2006)
Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease : 86 cases (2001-2005)
J Am Vet Med Assoc. 2006; 229: 1772-8
108. Serres F, Chetboul V, Tissier R, Sampedrano CC, Gouni V, Nicolle AP, Pouchelon JL (2007)
Chordae tendineae rupture in dogs with degenerative mitral valve disease: prevalence, survival, and prognostic factors (114 cases, 2001-2006)
J Vet Intern Med. 2007; 21: 258-64
109. Serres S, Chetboul V, Tissier R, Poujol L, Gouni V, Carlos Sampedrano C, Pouchelon JL (2008)
Comparison of 3 ultrasound methods for quantifying left ventricular systolic function: correlation with disease severity and pronostic value in dogs with mitral valve disease, J Vet Interne Med. 2008; 22: 566-77
110. SISSON D, KITTLESON MD (1999)
Management of heart failure: principles of treatment, therapeutic strategies, and pharmacology
In: Fox PR, Sisson D, Moïse NS, editors, 2nd ed. Philadelphia WB Saunders, Textbook of canine and feline cardiology: principles and clinical practice, 1999; 216-250
111. SISSON D, KVART C, DARKE PGG (1999)
Acquired valvular heart disease in dogs and cats
In: Fox PR, Sisson D, Moïse NS, editors, 2nd ed. Philadelphia: WB Saunders, Textbook of canine and feline cardiology: principles and clinical practice ; 536-565
112. Slupe JL, LM Freeman, JE Rush (2008)
Association of body weight and body condition with survival in dogs with heart failure
J Vet Intern Med. 2008; 22: 561-5
113. Smith P (2006)
Management of chronic degenerative mitral valve disease in dogs
In Practice. 2006; 28: 376-383
114. Smith PJ, French AT, Van Israël N, Smith SGW, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J (2005)
Efficacy and safety of pimobendane in canine heart failure caused by myxomatous mitral valve disease
J of Small Anim Pract. 2005; 46: 121-130
115. Souilem W, Barhoumi K (2005)
Principe actif le furosémide
Nouv Prat Vét canine féline. 2005; 22: 67-68
116. SOUILEM W, GOGNY M (2002)
Principe actif la digoxine
Nouv Prat Vét canine féline. 2002; 8: 55-56
117. Stepien RL (2009)
Pulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogs
J of Small Anim Pract. 2009; 50: S34-43
118. Stewart JA Jr, Wei CC, Brower GL, Rynders PE, Hankes GH, Dillon AR, Lucchesi PA, Janicki JS, Dell'Italia LJ (2003)
Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog
J Mol Cell Cardiol. 2003; 35: 311-9
119. Swenson L, Häggström J, Kvart C, Juneja RK (1996)
Relationship between parental cardiac status in Cavalier King Charles Spaniels and prevalence and severity of chronic valvular disease in offspring
J Am Vet Med Assoc. 1996; 208: 2009-12
120. Teerlink JR (1996)
Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system
J Cardiovasc Pharmacol. 1996; 27: S1-S8
121. Tessier-Vetzel D (2002)
Endothélines et peptides natriurétiques, une prise en charge de l’insuffisance cardiaque
Action Vét. Edition spéciale: cardiologie. 2002; 20-23
122. TESSIER-VETZEL D (2004)
Insuffisance cardiaque congestive : œdème pulmonaire et épanchements
In: Chetboul V, Lefebvre HP, Tessier-Vetzel D, Pouchelon JL, editors, Thérapeutique cardiovasculaire du chien et du chat. Paris: Masson-AFVAC; 2004, 141-53
123. Thomason JD, Rockwell JE, Fallaw TK, Calvert CA (2007)
Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease
J Vet Cardiol. 2007; 9: 103-8
124. Tilley LP, Smith FWK, Oyama MA, Sleeper MM (date ?)
Acquired valvular heart disease in dogs and cats
In : Manual of canine and feline cardiology 4th edition (page ?)
125. Uechi M, Iasayama N, Mizuno T, Ebisawa T, Yamano S, Mizuno M, Mizukoshi T (2008)
Hemodynamic effects of the combination of carvedilol and pimobendan in dogs
Je n’arrive plus à remettre la main sur la reference…
126. Vandaele E (2001)
Traitement de l’insuffisance cardiaque congestive. Le pimobendane, un vasodilatateur inotrope
Point Vét. 2001; Hors série n°1106
127. Vandaële E (2004)
Traitement des endocardioses chez le chien. Le pimobendane se révèle au moins aussi efficace que les IECA
Point Vét. 2004; 265: 6139-45
128. Ware WA Lund DD, Subieta AR, Schmid PG (1990)
Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy
J Am Vet Med Assoc. 1990; 197: 1475-1481
129. WHITNEY JC (1974)
Observations of the effect of age on the severity of heart valve lesions in the dog
J Small Anim Pract. 1974; 15: 511-522
130. YANG SS, HAN W, ZHOU HY, Dong G, Wang BC, Huo H, Wei N, Cao Y, Zhou G, Xiu CH, Li WM (2008)
Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure
Chin Med J. (Engl) 2008; 121: 38-42
131. The IMPROVE Study Group (1995)
Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study
J Vet Intern Med. 1995; 9: 234-42
132. The COVE Study Group (1995)
Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group
J Vet Intern Med. 1995; 9: 243-52
133. The BENCH Study Group (1999)
The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure : result of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trail: results of the BENazepril in Canine Heart Disease
Journal of Veterinary Cardiology. 1999; 1: 7-18
134. The BENCH Study Group (2004)
Long-term tolerability of benazepril in dogs with congestive heart failure
Journal of veterinary Cardiology. 2004; 6: 7-13
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.